Histone deacetylases: Salesmen and customers in the post-translational modification market

Biology of the Cell

Volumn 101, Issue 4, 2009, Pages 193-205

  Brandl, André ^a   Heinzel, Thorsten ^a   Krämer, Oliver H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cancer; Histone deacetylase; Post translational modification; Signalling

Indexed keywords

AURORA A KINASE; CYCLIN DEPENDENT KINASE 1; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PARKIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE C; PROTEIN MDM2; VALPROIC ACID; HISTONE; ISOENZYME;

ACETYLATION; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MARKER; DRUG TARGETING; GENE EXPRESSION REGULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION; CHEMISTRY; CLASSIFICATION; GENETICS; METABOLISM; PHOSPHORYLATION;

ACETYLATION; HISTONE DEACETYLASES; HISTONES; HUMANS; ISOENZYMES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITINATION;

EID: 61549116543     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20080158     Document Type: Review

References (92)

1. Atmaca, A., Al-Batran, S.E., Maurer, A., Neumann, A., Heinzel, T., Hentsch, B., Schwarz, S.E., Hövelmann, S., Göttlicher, M., Knuth, A. and Jäger, E. (2007) Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. Br. J. Cancer 97, 177-182
2. Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., Seto, E. and Bhalla, K. (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J. Biol. Chem. 280, 26729-26734
3. Bereshchenko, O.R., Gu, W. and Dalla-Favera, R. (2002) Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32, 606-613
4. Bloom, J., Amador, V., Bartolini, F., DeMartino, G. and Pagano, M. (2003) Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 115, 71-82
5. Bolden, J.E., Peart, M.J. and Johnstone, R.W. (2006) Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5, 769-784
6. Boyault, C., Zhang, Y., Fritah, S., Caron, C., Gilquin, B., Kwon, S.H., Garrido, C., Yao, T.P., Vourc'h, C., Matthias, P. and Khochbin, S. (2007) HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 21, 2172-2181
7. Brush, M.H., Guardiola, A., Connor, J.H., Yao, T.P. and Shenolikar, S. (2004) Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J. Biol. Chem. 279, 7685-7691
8. Bug, G., Ritter, M., Wassmann, B., Schoch, C., Heinzel, T., Schwarz, K., Romanski, A., Krämer, O.H., Kampfmann, M., Hoelzer, D. et al. (2005) Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 104, 2717-2725
9. Cai, R., Kwon, P., Yan-Neale, Y., Sambuccetti, L., Fischer, D. and Cohen, D. (2001) Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. Biochem. Biophys. Res. Commun. 283, 445-453
10. Cheng, J., Wang, D., Wang, Z. and Yeh, E.T. (2004) SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol. Cell. Biol. 24, 6021-6028
11. Colombo, R., Boggio, R., Seiser, C., Draetta, G.F. and Chiocca, S. (2002) The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep. 3, 1062-1068
12. David, G., Neptune, M.A. and DePinho, R.A. (2002) SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277, 23658-23663
13. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S. and van Kuilenburg, A.B. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749
14. Dequiedt, F., Van Lint, J., Lecomte, E., Van Duppen, V., Seufferlein, T., Vandenheede, J.R., Wattiez, R. and Kettmann, R. (2005) Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 201, 793-804
15. Dequiedt, F., Martin, M., Von Blume, J., Vertommen, D., Lecomte, E., Mari, N., Heinen, M.F., Bachmann, M., Twizere, J.C., Huang, M.C. et al. (2006) New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol. Cell. Biol. 26, 7086-7102
16. Duenas-Gonzalez, A., Candelaria, M., Perez-Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E. and Herrera, L.A. (2008) Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat. Rev. 34, 206-222
17. Fang, S. and Weissman, A.M. (2004) A field guide to ubiquitylation. Cell. Mol. Life Sci. 61, 1546-1561
18. Ford, J., Ahmed, S., Allison, S., Jiang, M. and Milner, J. (2008) JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 7, 3091-3097
19. Galasinski, S.C., Resing, K.A., Goodrich, J.A. and Ahn, N.G. (2002) Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J. Biol. Chem. 277, 19618-19626
20. Gaughan, L., Logan, I.R., Neal, D.E. and Robson, C.N. (2005) Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 33, 13-26
21. Geiss-Friedlander, R. and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. 8, 947-956
22. Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.E., Willson, T.M., Rosenfeld, M.G. and Glass, C.K. (2007) Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPAR?. Mol. Cell 25, 57-70
23. Glozak, M.A. and Seto, E. (2007) Histone deacetylases and cancer. Oncogene 26, 5420-5432
24. Göttlicher, M., Minucci, S., Zhu, P., Kramer, O.H., Schimpf, A., Giavara, S., Sleeman, J.P., Lo Coco, F., Nervi, C., Pelicci, P.G. and Heinzel, T. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969-6978
25. Gregoire, S. and Yang, X.J. (2005) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25, 2273-2287
26. Grozinger, C.M. and Schreiber, S.L. (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. U.S.A. 97, 7835-7840
27. Grozinger, C.M. and Schreiber, S.L. (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9, 3-16
28. Guidez, F., Howell, L., Isalan, M., Cebrat, M., Alani, R.M., Ivins, S., Hormaeche, I., McConnell, M.J., Pierce, S., Cole, P.A. et al. (2005) Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25, 5552-5566
29. Guo, C., Mi, J., Brautigan, D.L. and Larner, J.M. (2007) ATM regulates ionizing radiation-induced disruption of HDAC1:PP1:Rb complexes. Cell. Signal. 19, 504-510
30. Hay, R.T. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12
31. Heinzel, T. and Krämer, O.H. (2008) Pharmacodynamic markers for histone deacetylase inhibitor development. Drug Discov. Today 4, 277-283
32. Hildmann, C., Riester, D. and Schwienhorst, A. (2007) Histone deacetylases-an important class of cellular regulators with a variety of functions. Appl. Microbiol. Biotechnol. 75, 487-497
33. Hook, S.S., Orian, A., Cowley, S.M. and Eisenman, R.N. (2002) Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc. Natl. Acad. Sci. U.S.A. 99, 13425-13430
34. Hrzenjak, A., Moinfar, F., Kremser, M.L., Strohmeier, B., Staber, P.B., Zatloukal, K. and Denk, H. (2006) Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol. Cancer Ther. 5, 2203-2210
35. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science 293, 1074-1080
36. Johnson, C.A., White, D.A., Lavender, J.S., O'Neill, L.P. and Turner, B.M. (2002) Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. J. Biol. Chem. 277, 9590-9597
37. Joseph, J., Mudduluru, G., Antony, S., Vashistha, S., Ajitkumar, P. and Somasundaram, K. (2004) Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23, 6304-6315
38. Karwowska-Desaulniers, P., Ketko, A., Kamath, N. and Pflum, M.K. (2007) Histone deacetylase 1 phosphorylation at S421 and S423 is constitutive invivo, but dispensable invitro. Biochem. Biophys. Res. Commun. 361, 349-355
39. Kawaguchi, Y., Kovacs, J.J., McLaurin, A., Vance, J.M., Ito, A. and Yao, T.P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727-738
40. Khochbin, S., Verdel, A., Lemercier, C. and Seigneurin-Berny, D. (2001) Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11, 162-166
41. Kirsh, O., Seeler, J.S., Pichler, A., Gast, A., Muller, S., Miska, E., Mathieu, M., Harel-Bellan, A., Kouzarides, T., Melchior, F. and Dejean, A. (2002) The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21, 2682-2691
42. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705
43. Krämer, O.H., Göttlicher, M. and Heinzel, T. (2001) Histone deacetylase as a therapeutic target. Trends Endocrinol. Metab. 12, 294-300
44. Krämer, O.H., Zhu, P., Ostendorff, H.P., Golebiewski, M., Tiefenbach, J., Peters, M.A., Brill, B., Groner, B., Bach, I., Heinzel, T. and Göttlicher, M. (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 22, 3411-3420
45. Krämer, O.H., Baus, D., Knauer, S.K., Stein, S., Jäger, E., Stauber, R.H., Grez, M., Pfitzner, E. and Heinzel, T. (2006) Acetylation of Stat1 modulates NF-κB activity. Genes Dev. 20, 473-485
46. Krämer, O.H., Müller, S., Buchwald, M., Reichardt, S. and Heinzel, T. (2008a) Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARα. FASEB J. 22, 1369-1379
47. Krämer, O.H., Knauer, S.K., Zimmermann, D., Stauber, R.H. and Heinzel, T. (2008b) Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis. Oncogene 27, 732-740
48. Langley, E., Pearson, M., Faretta, M., Bauer, U.M., Frye, R.A., Minucci, S., Pelicci, P.G. and Kouzarides, T. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383-2396
49. Lee, H., Rezai-Zadeh, N. and Seto, E. (2004) Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 24, 765-773
50. Li, X., Song, S., Liu, Y., Ko, S.H. and Kao, H.Y. (2004) Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J. Biol. Chem. 279, 34201-34208
51. Martin, M., Kettmann, R. and Dequiedt, F. (2007) Class IIa histone deacetylases: regulating the regulators. Oncogene 26, 5450-5467
52. Martin, M., Potente, M., Janssens, V., Vertommen, D., Twizere, J.C., Rider, M.H., Goris, J., Dimmeler, S., Kettmann, R. and Dequiedt, F. (2008) Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 105, 4727-4732
53. McKinsey, T.A., Zhang, C.L., Lu, J. and Olson, E.N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111
54. Melchior, F., Schergaut, M. and Pichler, A. (2003) SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28, 612-618
55. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M. and Gannon, F. (2003) Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763
56. Meulmeester, E. and Melchior, F. (2008) Cell biology: SUMO. Nature 452, 709-711
57. Michan, S. and Sinclair, D. (2007) Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13
58. Moreira, J.M., Scheipers, P. and Sorensen, P. (2003) The histone deacetylase inhibitor trichostatin A modulates CD4+ T cell responses. BMC Cancer 3, 30
59. Nusinzon, I. and Horvath, C.M. (2003) Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. U.S.A. 100, 14742-14747
60. Paroni, G., Cernotta, N., Dello Russo, C., Gallinari, P., Pallaoro, M., Foti, C., Talamo, F., Orsatti, L., Steinkuhler, C. and Brancolini, C. (2008) PP2A regulates HDAC4 nuclear import. Mol. Biol. Cell 19, 655-667
61. Parra, M., Mahmoudi, T. and Verdin, E. (2007) Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes. Genes Dev. 21, 638-643
62. Passmore, L.A. and Barford, D. (2004) Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem. J. 379, 513-525
63. Petrie, K., Guidez, F., Howell, L., Healy, L., Waxman, S., Greaves, M. and Zelent, A. (2003) The histone deacetylase 9 gene encodes multiple protein isoforms. J. Biol. Chem. 278, 16059-16072
64. Pflum, M.K., Tong, J.K., Lane, W.S. and Schreiber, S.L. (2001) Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J. Biol. Chem. 276, 47733-47741
65. Pluemsampant, S., Safronova, O.S., Nakahama, K. and Morita, I. (2008) Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors. Int. J. Cancer 122, 333-341
66. Pugacheva, E.N., Jablonski, S.A., Hartman, T.R., Henske, E.P. and Golemis, E.A. (2007) HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 129, 1351-1363
67. Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B.S., Huang, S., Hendarwanto, A., Martinez, E.D., Chen, Y., Lu, H. et al. (2006) HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22, 669-679
68. Rosenfeld, M.G., Lunyak, V.V. and Glass, C.K. (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405-1428
69. Schreiber, S.L. and Bernstein, B.E. (2002) Signaling network model of chromatin. Cell 111, 771-778
70. Seigneurin-Berny, D., Verdel, A., Curtet, S., Lemercier, C., Garin, J., Rousseaux, S. and Khochbin, S. (2001) Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol. Cell. Biol. 21, 8035-8044
71. Spange, S., Wagner, T., Heinzel, T. and Kramer, O.H. (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 41, 185-198
72. Stankovic-Valentin, N., Deltour, S., Seeler, J., Pinte, S., Vergoten, G., Guerardel, C., Dejean, A. and Leprince, D. (2007) An acetylation/ deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27, 2661-2675
73. Sun, J.M., Chen, H.Y., Moniwa, M., Litchfield, D.W., Seto, E. and Davie, J.R. (2002) The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J. Biol. Chem. 277, 35783-35786
74. Sun, J.M., Chen, H.Y. and Davie, J.R. (2007) Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin. J. Biol. Chem. 282, 33227-33236
75. Tatham, M.H., Jaffray, E., Vaughan, O.A., Desterro, J.M., Botting, C.H., Naismith, J.H. and Hay, R.T. (2001) Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374
76. Tou, L., Liu, Q. and Shivdasani, R.A. (2004) Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol. Cell. Biol. 24, 3132-3139
77. Tsai, S.C. and Seto, E. (2002) Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem. 277, 31826-31833
78. Um, J.W., Min, D.S., Rhim, H., Kim, J., Paik, S.R. and Chung, K.C. (2006) Parkin ubiquitinates and promotes the degradation of RanBP2. J. Biol. Chem. 281, 3595-3603
79. Vashisht Gopal, Y.N., Arora, T.S. and Van Dyke, M.W. (2006) Tumour necrosis factor-a depletes histone deacetylase 1 protein through IKK2. EMBO Rep. 7, 291-296
80. Verdin, E., Dequiedt, F. and Kasler, H.G. (2003) Class II histone deacetylases: versatile regulators. Trends Genet. 19, 286-293
81. Wang, G., Ahmad, K.A., Unger, G., Slaton, J.W. and Ahmed, K. (2006) CK2 signaling in androgen-dependent and -independent prostate cancer. J. Cell. Biochem. 99, 382-391
82. Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R. and Olson, E.N. (2008) Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc. Natl. Acad. Sci. U.S.A. 105, 7738-7743
83. Wiper-Bergeron, N., Wu, D., Pope, L., Schild-Poulter, C. and Hache, R.J. (2003) Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22, 2135-2145
84. Yang, X.J. (2004) Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26, 1076-1087
85. Yang, X.J. and Seto, E. (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310-5318
86. Yang, X.J. and Seto, E. (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. 9, 206-218
87. Yang, Y., Fu, W., Chen, J., Olashaw, N., Zhang, X., Nicosia, S.V., Bhalla, K. and Bai, W. (2007) SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262
88. Zhang, C.L., McKinsey, T.A., Chang, S., Antos, C.L., Hill, J.A. and Olson, E.N. (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488
89. Zhang, X., Ozawa, Y., Lee, H., Wen, Y.D., Tan, T.H., Wadzinski, B.E. and Seto, E. (2005) Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19, 827-839
90. Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.L., Chua, K. et al. (2008) Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell. Biol. 28, 1688-1701
91. Zhao, X., Sternsdorf, T., Bolger, T.A., Evans, R.M. and Yao, T.P. (2005) Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol. 25, 8456-8464
92. Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.P. and Göttlicher, M. (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463